队列概况:加纳艾滋病毒患者 (GenoPharm-GH) 的药物基因组学和药物动力学研究
Nicholas Ekow Thomford1,2,3,4, Oksana Ryabinina5,6, Joel Adu Twum5
1Pharmacogenomics and Genomic Medicine Group, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana. nthomford@ucc.edu.gh.
BMC genomic data
|November 25, 2025
概括
该GenoPharm-GH研究跟踪了加纳的艾滋病毒治疗,分析了遗传学和并发症,以改善患者的治疗结果. 目前正在进行的研究旨在个性化抗逆转录病毒疗法,以获得更好的结果.
科学领域:
- 艾滋病毒/艾滋病研究研究
- 药物遗传学 药物遗传学
- 加纳的公共卫生.
背景情况:
- 2019年启动的GenoPharm-GH项目是一项纵向的,多地点的观察性队列研究.
- 它旨在了解宿主遗传学,药理动力学和并发症如何影响加纳艾滋病毒感染者 (PLWH) 的治疗结果.
研究的目的:
- 研究宿主基因对抗逆转录病毒治疗 (ART) 反应的影响.
- 评估药理动力学和并发症对治疗结果的影响.
- 在加纳背景下弥合艾滋病毒管理方面的知识差距.
主要方法:
- 未来的,纵向的,多站点的队列研究,涉及超过2044 PLWH (年龄≥8年) 的ART.
- 数据收集包括病毒抑制,坚持,临床数据,遗传变异,共感染和并发症.
- 样品存储在生物储存库中,用于正在进行和未来的分析.
主要成果:
- 超过95%的参与者正在服用基于多卢特格拉维尔的ART,其中58%的人达到病毒载量<50副本/毫升.
- 10-15%的人经历病毒学失败 (>1000cp/mL).
- 已经确定了杜洛特格拉维尔的药物遗传数据 (CYP3A4,CYP3A5,UGT1A1,ApoE) 和代谢物概况. 常见的共感染和并发病包括病毒性肝炎,结核病,肺炎,糖尿病和高血压.
结论:
- 该研究为转化性艾滋病毒研究提供了一个平台,为政策提供信息并改善长期结果.
- 扩大生物银行和随访将提高对治疗动态的理解,并支持个性化艾滋病毒护理.
- 定期更新数据对于理解治疗结果动态和指导治疗干预至关重要.
相关概念视频
Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659
Bioavailability Study Design: Healthy Subjects Versus Patients
136
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
136
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
170
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
189
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
189
Pharmacokinetics: Overview
8.7K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
8.7K
Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K


